Developing therapeutic monoclonal antibodies at pandemic pace

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

Davide Corti, Jarrod Voss, S.J. Gamblin et al. · Science · 2011 · 1.2K citations

Pharmacy, Immunology, Infectious Diseases +17

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

Karin Stettler, Martina Beltramello, Diego A. Espinosa et al. · Science · 2016 · 787 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Zhongyu Zhu, Samitabh Chakraborti, Yuxian He et al. · Proceedings of the National Academy of Sciences · 2007 · 307 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

High‐throughput screening of chromatographic separations: I. Method development and column modeling

Jon Coffman, Jack F. Kramarczyk, Brian D. Kelley · Biotechnology and Bioengineering · 2008 · 212 citations · Full text

Pharmacy, Biochemistry, Pharmaceutical Analysis +17

Weak partitioning chromatography for anion exchange purification of monoclonal antibodies

Brian D. Kelley, Scott A. Tobler, Paul Brown et al. · Biotechnology and Bioengineering · 2008 · 145 citations

Life Sciences, Biochemistry, Biotechnology +17